NASDAQ: BCRX · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

BioCryst Pharmaceuticals Inc.

How BioCryst Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.2B

Price

$8.52

P/E

-5.7

EPS (TTM)

$-1.51

1-year return

16.6%

Dividend yield

0.0%

52-week range

$7.03–$8.55

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources